Analysis reveals altered brain connectivity and glymphatic dysfunction in medication overuse headache patients, indicating potential biomarkers.
Motivation: The glymphatic system (GS) and brain function are involoved in Medication overuse headache (MOH) pathophysiology. Goal(s): To investigate differences in GS and brain function in MOH versus episodic migraine (EM) and healthy controls (HCs), and correlations between GS, brain function, and clinical parameters in MOH. Approach: We evaluated the analysis along the perivascular space (ALPS) index, mean amplitude of low-frequency fluctuations (mALFF) and regional homogeneity (Reho) in 49 MOH patients, 54 EM patients, and 45 HCs using 7T. Results: MOH patients showed a lower ALPS index, higher mALFF, and altered FC, with ALPS index correlating with FC, pain degree, and duration in MOH. Impact: The ALPS index and functional changes may serve as a sensitive neuroimaging biomarker for predicting the progression from EM to MOH. And they may interact with each other in the pathogenesis of patients with MOH, collectively influencing the disease mechanism.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: